Clinical Efficiency of Huayu Xiaozhong Decoction on Preventing Peri-operative Deep Venous Thrombosis in Lower Limbs Following Artificial Total Hip Replacement
10.13359/j.cnki.gzxbtcm.2015.06.010
- VernacularTitle:化瘀消肿汤预防人工股骨头置换术后下肢深静脉血栓形成的围手术期临床效能
- Author:
Meixiong CHEN
;
Yewu LIN
;
Li ZHOU
;
Jian HUANG
;
Mingkui XU
;
Xihui ZHANG
;
Riming XU
;
Shiguo YUAN
- Publication Type:Journal Article
- Keywords:
Huayu Xiaozhong Decoction;
Artificial total hip replacement;
Lower limb deep venous thrombosis;
Peri-operation period
- From:
Journal of Guangzhou University of Traditional Chinese Medicine
2015;32(6):1011-1016
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical efficiency of Huayu Xiaozhong Decoction (HXD) on preventing peri-operative deep venous thrombosis (DVT) in lower limbs following artificial total hip replacement. Methods Ninety cases following artificial total hip replacement were randomized into blank control group, Rivaroxaban group and HXD group, 30 cases in each group, and were treated with brown sugar water, Rivaroxaban, HXD respectively. Before operation, and one, 3 and 14 days after operation, we monitored the changes of bleeding volume, DVT incidence, hemoglobin, prothrombin time ( PT) , activated partial thromboplastin time ( APTT) , international normalized ratio (INR), and D-dimer (DD) in the three groups. Results (1) Fifteen cases had DVT, with a total incidence rate of 16.67%. Of the 15 cases, 10 were from blank control group, 2 from Rivaroxaban group, and 3 from HXD group. ( 2) The amount of bleeding volume of Rivaroxaban group was larger than that of the blank control group and HXD group (P<0.05), but the bleeding was mild. (3) One, 3 and 14 days after operation, PT and APTT were shortened in blank control group (P<0.01 compared with those before operation). PT, APTT and INR were prolonged, and coagulation function was improved in Rivaroxaban group and HXD group, the differences being significant as compared with the blank control group ( P<0.05). HXD group had better effect on improving INR than Rivaroxaban group ( P<0.05). ( 4) In the three groups, hemoglobin level began to decrease on postoperative day one, arrived to the bottom on postoperative day 3 (P<0.05), and rose up near to the normal level on postoperative day 14; HXD group had higher hemoglobin level than blank control group and Rivaroxaban group on postoperative day 3 and 14 ( P<0.05). The 3 groups had higher plasma DD level than the normal level before the operation, arrived to the highest level on postoperative day one and 3 ( P<0.05) , and fell down near to the normal level on postoperative day 14. The inter-group comparison results showed that Rivaroxaban group and HXD group had lower DD level than the blank control group on postoperative day 3 and 14 ( P<0.05). Conclusion HXD is effective on preventing DVT in the peri-operation period through reducing bleeding, increasing hemoglobin level and improving postoperative anemia. The efficiency and safety of HXD are similar to Rivaroxaban.
